|
⚲
|
| Keyboard |
| Alan Colowick | |
|---|---|
| Firm | |
| Address | c/o Solve Therapeutics, Inc 1025 Alameda de Las Pulgas, Suite 122 Belmont, CA 94002 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| Solve Therapeutics Inc | 021-564959 | Director | 48.2 M of 120.5 M |
||
| Recode Therapeutics Inc | 021-561915 | Director | 29.4 M of 29.4 M |
||
| Solve Therapeutics Inc | 021-533368 | Director | 50.4 M of 75.6 M |
||
| Alumis Inc | 021-519656 | Director | 40.0 M of 40.0 M |
||
| Alumis Inc | 021-507205 | Director | 129.5 M of 259.0 M |
||
| Harpoon Therapeutics Inc | 021-478285 | Director | 25.0 M of 25.0 M |
||
| Anumana Inc | 021-465157 | Director | 32.0 M of 32.0 M |
||
| Solve Therapeutics Inc | 021-430372 | Director | 63.5 M of 126.5 M |
||
| Recode Therapeutics Inc | 021-418416 | Director | 259.8 M of 290.0 M |
||
| Incarda Therapeutics Inc | 021-378475 | Director | 28.0 M of 50.0 M |
||
| Velosbio Inc | 021-370879 | Director | 137.0 M of 137.0 M |
||
| Incarda Therapeutics Inc | 021-352920 | Director | 35.3 M of 42.1 M |
||
| Velosbio Inc | 021-323159 | Director | 59.3 M of 59.3 M |
||
| Principia Biopharma Inc | 021-320699 | Director | 50.0 M of 50.0 M |
||
| Achaogen Inc | 021-286870 | Director | 10.0 M of 10.0 M |
||
| Achaogen Inc | 021-264954 | Director | 25.4 M of 32.8 M |
||
| NORA Therapeutics Inc | 021-148095 | Executive Officer | 14.9 M of 32.6 M |
||
| Gloucester Pharmaceuticals Inc | 021-70770 | Executive Officer | 20.3 M of 28.9 M |
||